Adverse Effect Of Vaccine
- All
- News
- Videos
-
Can Smoking And Air Pollution Influence The Risk Of Pneumonia?
- Monday November 11, 2024
- Aayushi Singh Chauhan
Understanding how smoking and air pollution contribute to pneumonia risk can help individuals make informed choices about protecting their respiratory health.
- doctor.ndtv.com
-
Over 30% Covaxin Takers Suffered Health Issues After A Year, Claims Study
- Thursday May 16, 2024
- India News | Press Trust of India
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow-up study conducted at BHU.
- www.ndtv.com
-
Mixing AstraZeneca, Sputnik Shows "No Serious Adverse Effects": Report
- Friday July 30, 2021
- World News | Press Trust of India
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces initial safety results of the world's first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine.
- www.ndtv.com
-
"Significant Effect Unlikely If Doses Mixed": Centre After UP Mix-Up
- Thursday May 27, 2021
- India News | Edited by Chandrashekar Srinivasan
Significant adverse effects are "unlikely" if an individual's second Covid vaccine dose is different from the first, the centre said Thursday afternoon, in response to controversy over a group of Uttar Pradesh villagers being given mixed doses.
- www.ndtv.com
-
Looking At All Adverse Events: India On Concern Over AstraZeneca Shots
- Sunday March 14, 2021
- India News | Reported by Rishika Baruah, Ruby Dhingra, Edited by Swati Bhasin
India is lookin at all "serious" post-vaccination side effects as it carries out the world's largest coronavirus immunisation drive, a top medical expert said today amid suspension of AstraZeneca shots in at least four nations over risk of blood clots.
- www.ndtv.com
-
Adverse Event Cases After Coronavirus Vaccination Just 1 In 2,000: Centre
- Tuesday February 16, 2021
- India News | Press Trust of India
Just one out of 2,000 beneficiaries report minor effects post vaccination against COVID-19, the Centre said on Tuesday, noting that the rate of adverse event following immunisation has been recorded at 0.05 per cent.
- www.ndtv.com
-
"Upsetting That Some Healthcare Workers Declining Vaccine," Says Centre
- Tuesday January 19, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Debanish Achom
Doctors, nurses and others involved in fighting the COVID-19 pandemic should not hesitate the get themselves vaccinated, the government said today. Top medical experts and members of the government think tank NITI Aayog have requested people eligible for vaccination not to fall for rumours on safety, and that minor adverse effects are common and sh...
- www.ndtv.com
-
"In Case Of Adverse Events...": What Covaxin Consent Form Says
- Saturday January 16, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Deepshikha Ghosh
As India's vaccination drive began today with Covid shots to health workers, those receiving Bharat Biotech's Covaxin were asked to sign consent forms that assured compensation if any adverse effect was found linked to the vaccine.
- www.ndtv.com
-
Bhopal Vaccine Volunteer Death Unrelated To Dose: Bharat Biotech
- Saturday January 9, 2021
- India News | Written by Anurag Dwary
The death of a 45-year-old man in Madhya Pradesh's Bhopal - a volunteer for Phase III trials for Covaxin - was due to "other reasons" and not a severe adverse effect, Dr Anil Dixit, the Dean of the city's People's Medical College, said on Friday
- www.ndtv.com
-
Covaxin Triggers Immune Response, No Adverse Effects In Phase 1 Trial
- Wednesday December 16, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Chandrashekar Srinivasan
Covaxin, which is one of three coronavirus vaccine candidates being considered for emergency use authorisation in India, induced an immune response and registered no serious adverse events, interim findings of Phase I trials have revealed
- www.ndtv.com
-
"Can't Deny Possibility, Must Be Ready": Centre On Covid Vaccine Adverse Events
- Tuesday December 15, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Chandrashekar Srinivasan
Protocols have been established for the management of adverse reactions - minor, severe or serious - to the coronavirus vaccine, the government said in a press briefing held Tuesday evening, as it admitted there is "possibility of an adverse event"
- www.ndtv.com
-
UK Warns Against Pfizer Vaccine For Those With Serious Allergies After 2 Reactions
- Wednesday December 9, 2020
- World News | Reuters
Britain's medicine regulator has advised that people with a history of significant allergic reactions do not get Pfizer-BioNTech's COVID-19 vaccine after two people reported adverse effects on the first day of rollout.
- www.ndtv.com
-
Centre Rejects Volunteer's Claim, Clears Oxford Vaccine Trials In India
- Tuesday December 1, 2020
- India News | Reported by Vishnu Som, Edited by Deepshikha Ghosh
The government today said it had found no reason to stop the Oxford vaccine trials in India after reviewing a Chennai volunteer's allegation of serious adverse effects, including memory loss and change in behavior.
- www.ndtv.com
-
"He Lost Ability To Do Simple Tasks": Vaccine Volunteer's Wife To NDTV
- Wednesday December 2, 2020
- India News | Reported by J Sam Daniel Stalin, Edited by Deepshikha Ghosh
A Chennai volunteer whose allegations of adverse effects from the Oxford vaccine trials have led to a 100-crore lawsuit by Serum Institute of India (SII), lost an American job and has found it difficult to do even simple tasks, his wife has said.
- www.ndtv.com
-
Serum Institute Says "Incident With Volunteer No Way Induced By Vaccine"
- Tuesday December 1, 2020
- India News | Edited by Deepshikha Ghosh
The Oxford coronavirus vaccine is "safe and immunogenic", the Serum Institute of India has asserted today, battling a massive controversy over a trial volunteer in Chennai alleging adverse effects including "virtual neurological breakdown, memory loss and behavioral changes".
- www.ndtv.com
-
Can Smoking And Air Pollution Influence The Risk Of Pneumonia?
- Monday November 11, 2024
- Aayushi Singh Chauhan
Understanding how smoking and air pollution contribute to pneumonia risk can help individuals make informed choices about protecting their respiratory health.
- doctor.ndtv.com
-
Over 30% Covaxin Takers Suffered Health Issues After A Year, Claims Study
- Thursday May 16, 2024
- India News | Press Trust of India
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow-up study conducted at BHU.
- www.ndtv.com
-
Mixing AstraZeneca, Sputnik Shows "No Serious Adverse Effects": Report
- Friday July 30, 2021
- World News | Press Trust of India
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces initial safety results of the world's first study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine.
- www.ndtv.com
-
"Significant Effect Unlikely If Doses Mixed": Centre After UP Mix-Up
- Thursday May 27, 2021
- India News | Edited by Chandrashekar Srinivasan
Significant adverse effects are "unlikely" if an individual's second Covid vaccine dose is different from the first, the centre said Thursday afternoon, in response to controversy over a group of Uttar Pradesh villagers being given mixed doses.
- www.ndtv.com
-
Looking At All Adverse Events: India On Concern Over AstraZeneca Shots
- Sunday March 14, 2021
- India News | Reported by Rishika Baruah, Ruby Dhingra, Edited by Swati Bhasin
India is lookin at all "serious" post-vaccination side effects as it carries out the world's largest coronavirus immunisation drive, a top medical expert said today amid suspension of AstraZeneca shots in at least four nations over risk of blood clots.
- www.ndtv.com
-
Adverse Event Cases After Coronavirus Vaccination Just 1 In 2,000: Centre
- Tuesday February 16, 2021
- India News | Press Trust of India
Just one out of 2,000 beneficiaries report minor effects post vaccination against COVID-19, the Centre said on Tuesday, noting that the rate of adverse event following immunisation has been recorded at 0.05 per cent.
- www.ndtv.com
-
"Upsetting That Some Healthcare Workers Declining Vaccine," Says Centre
- Tuesday January 19, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Debanish Achom
Doctors, nurses and others involved in fighting the COVID-19 pandemic should not hesitate the get themselves vaccinated, the government said today. Top medical experts and members of the government think tank NITI Aayog have requested people eligible for vaccination not to fall for rumours on safety, and that minor adverse effects are common and sh...
- www.ndtv.com
-
"In Case Of Adverse Events...": What Covaxin Consent Form Says
- Saturday January 16, 2021
- India News | Reported by Sukirti Dwivedi, Edited by Deepshikha Ghosh
As India's vaccination drive began today with Covid shots to health workers, those receiving Bharat Biotech's Covaxin were asked to sign consent forms that assured compensation if any adverse effect was found linked to the vaccine.
- www.ndtv.com
-
Bhopal Vaccine Volunteer Death Unrelated To Dose: Bharat Biotech
- Saturday January 9, 2021
- India News | Written by Anurag Dwary
The death of a 45-year-old man in Madhya Pradesh's Bhopal - a volunteer for Phase III trials for Covaxin - was due to "other reasons" and not a severe adverse effect, Dr Anil Dixit, the Dean of the city's People's Medical College, said on Friday
- www.ndtv.com
-
Covaxin Triggers Immune Response, No Adverse Effects In Phase 1 Trial
- Wednesday December 16, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Chandrashekar Srinivasan
Covaxin, which is one of three coronavirus vaccine candidates being considered for emergency use authorisation in India, induced an immune response and registered no serious adverse events, interim findings of Phase I trials have revealed
- www.ndtv.com
-
"Can't Deny Possibility, Must Be Ready": Centre On Covid Vaccine Adverse Events
- Tuesday December 15, 2020
- India News | Reported by Sukirti Dwivedi, Edited by Chandrashekar Srinivasan
Protocols have been established for the management of adverse reactions - minor, severe or serious - to the coronavirus vaccine, the government said in a press briefing held Tuesday evening, as it admitted there is "possibility of an adverse event"
- www.ndtv.com
-
UK Warns Against Pfizer Vaccine For Those With Serious Allergies After 2 Reactions
- Wednesday December 9, 2020
- World News | Reuters
Britain's medicine regulator has advised that people with a history of significant allergic reactions do not get Pfizer-BioNTech's COVID-19 vaccine after two people reported adverse effects on the first day of rollout.
- www.ndtv.com
-
Centre Rejects Volunteer's Claim, Clears Oxford Vaccine Trials In India
- Tuesday December 1, 2020
- India News | Reported by Vishnu Som, Edited by Deepshikha Ghosh
The government today said it had found no reason to stop the Oxford vaccine trials in India after reviewing a Chennai volunteer's allegation of serious adverse effects, including memory loss and change in behavior.
- www.ndtv.com
-
"He Lost Ability To Do Simple Tasks": Vaccine Volunteer's Wife To NDTV
- Wednesday December 2, 2020
- India News | Reported by J Sam Daniel Stalin, Edited by Deepshikha Ghosh
A Chennai volunteer whose allegations of adverse effects from the Oxford vaccine trials have led to a 100-crore lawsuit by Serum Institute of India (SII), lost an American job and has found it difficult to do even simple tasks, his wife has said.
- www.ndtv.com
-
Serum Institute Says "Incident With Volunteer No Way Induced By Vaccine"
- Tuesday December 1, 2020
- India News | Edited by Deepshikha Ghosh
The Oxford coronavirus vaccine is "safe and immunogenic", the Serum Institute of India has asserted today, battling a massive controversy over a trial volunteer in Chennai alleging adverse effects including "virtual neurological breakdown, memory loss and behavioral changes".
- www.ndtv.com